BHI Slovakia

BHI Slovakia is a biotechnology company and clinical research center focused on the development and application of regenerative medicine and stem cell therapies. As a subsidiary of Blue Horizon International (BHI) Therapeutic Sciences, the company operates a specialized facility in Malacky, Slovakia, where it conducts clinical trials and provides treatments using umbilical cord-derived mesenchymal stem cells. Their research primarily targets orthopedic conditions, neurological disorders, and chronic inflammatory diseases. BHI Slovakia integrates advanced laboratory processing with clinical application to advance the field of cellular therapy within the European Union. The company serves as a strategic hub for BHI's global clinical research efforts, leveraging local medical expertise and infrastructure.